Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Share News (ONC)

Share Price Information for Oncimmune (ONC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.00
Bid: 11.50
Ask: 11.80
Change: -2.45 (-17.38%)
Spread: 0.30 (2.609%)
Open: 13.50
High: 13.50
Low: 11.00
Prev. Close: 14.10
ONC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: Topps Tiles in strategic shift as swings to loss

Tue, 21st May 2024 16:27

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Oncimmune Holdings PLC - Nottingham, England-based immunodiagnostics developer - Reports results for the six months ended February. Revenue rises 6.3% to GBP1.19 million from GBP1.12 million. Pretax loss for continuing operations narrows to GBP1.1 million from GBP5.9 million, basic and diluted loss per share is 0.015 pence compared to 8.47p. "Whilst we are seeing continuing headwinds in the industry as a whole, with some of the large international pharma companies still undertaking restructurings and reassessing R&D programmes, I am confident that our differentiated service offering, which we continue to develop and expand, will become an important tool for our current and future customers," says Chief Executive Martin Gouldstone.

----------

IXICO PLC - neuroscience focused advanced analytics company - Reports results for the six months ended March 31. Pretax loss widens to GBP1.5 million from GBP884,000 a year prior on revenue down 28% to GBP2.5 million from GBP3.2 million. Cost of sales falls 12% to GBP1.5 million from GBP1.7 million, but total operating costs rise 12% to GBP2.9 million from GBP2.6 million. Says revenue performance has been challenging albeit consistent with the slow-down in capital markets funding of the biotech market. But, sees a turn in market conditions, and subsequent to the half-year end says new contracts have been signed and further contracts awarded. Remains confident of the market opportunity and its "Precision in Neuroscience" strategy and expects to see this deliver increased value in the coming periods.

----------

GetBusy PLC - Cambridge, England-based document management and productivity software provider - Issues trading update ahead of Tuesday's Annual General Meeting. Continues to make good operational progress towards its strategic goals. Says annualised recurring revenue at April 30 was around GBP20.8 million up 1.5% from GBP20.5 million at December 31. Reconfirms expectations for the year and remains "very encouraged" about the long-term value creation and realisation prospects for the group. Says expectations for the year-ending December 31 are revenue of GBP22.9 million and adjusted earnings before interest, tax, depreciation and amortisation of GBP1.2 million.

----------

Fintel PLC - Huddersfield, England-based provider of technology and support services to UK retail financial services sector - Issues trading update ahead of Tuesday's annual general meeting. Continues to execute against its strategy and says trading is in line with expectations. Highlights further strategic progress, completing four complementary acquisitions and investments since the start of the year. Remains well positioned to capitalise on organic growth opportunities with cash position of GBP10.6 million at at April 30. Fintel says it "remains confident that Fintel's strategy will deliver sustainable long-term growth, underpinned by positive market dynamics and structural growth drivers including evolving regulation, [Financial Conduct Authority] Consumer Duty and demand for technology and data."

----------

FD Technologies PLC - County Down, Northern Ireland-based group comprising several data-driven businesses, including technology and digital solutions providers KX, First Derivative, and MRP - Reports results for the year ended February 29. Pretax loss widens to GBP7.7 million from GBP0.4 million a year prior as revenue falls 2.2% to GBP248.9 million from GBP254.6 million. Diluted loss per share widens to 145.2 pence from 14.4p. Says performance was impacted by lower pipeline conversion rates and lengthened sales cycles, resulting from a combination of having fewer repeatable use cases in newer markets and macroeconomic headwinds. Notes an improvement in bookings in the fourth quarter at First Derivative but says the market remains cautious. Looking ahead to financial 2025, expects First Derivative revenue between GBP160 million to GBP170 million, at maintained Ebitda margins.

----------

Calnex Solutions PLC - Linlithgow, Scotland provider of test and measurement solutions for the global telecommunications sector - Reports results for the year to March 31. Swings to pretax loss of GBP384,000 from a pretax profit of GBP7.2 million a year prior. This comes as revenue falls 41% to GBP16.3 million from GBP27.4 million. Basic earnings per share is 0.05 pence compared with 6.75p. Explains performance was impacted by the wider economic environment and resulting deferral of investment in telecoms market. Proposes final dividend of 0.62p per share making the total payout unchanged at 0.93p from a year ago. Notes recently launched products are gaining traction, providing confidence in a return to growth in financial 2025. Challenges across the wider telecoms market are expected to remain for the year but the fundamental long-term need for telecoms testing solutions remains unchanged, company says.

----------

Topps Tiles PLC - Leicester-based tile retailer - Issues results for the 26 weeks ended March 30. Swings to pretax loss of GBP1.5 million from pretax profit of GBP1.7 million a year prior, as revenue falls by 5.8% to GBP122.8 million from GBP130.3 million. Dividend is left unchanged at 1.2 pence per share. Says drop in sales driven by lower footfall in Topps Tiles. Adds sales over the first seven weeks of the second half were 7.3% lower year-on-year with Topps Tiles like-for-like sales were 10% lower year-on-year. Macroeconomic lead indicators such as GDP, mortgage approvals and customer confidence are all improving, however trading results are yet to benefit from these upsides, company says. Chief Executive Rob Parker says: "Trading conditions in the first half have been challenging in a tile market which is down 20% on 2019. Against this backdrop, we are continuing to take market share, our online pure play businesses are growing strongly and the Group remains in a robust financial position." Further, launches new updated strategy - "Mission 365." New goal is to grow group sales to GBP365 million in the medium term, with 8% to 10% adjusted pretax profit margins. Addressable market expands to include hard wall and floor surface coverings and related products. Plans significantly upgraded digital offer and new, co-ordinated growth strategy. Proposes further expansion of online pure-play businesses Pro-Tiler and Tile Warehouse.

----------

Diaceutics PLC - Belfast-based provider of diagnostic commercialisation services to pharmaceutical and biotechnology companies - Reports results for the year to December 31. Swings to pretax loss of GBP2.4 million from GBP0.6 million profit a year prior although revenue rises to GBP23.7 million from GBP19.5 million. Order book stands at GBP26.5 million at December 31 up 57% from GBP16.9 million at the end of 2022. Chief Executive Ryan Keeling says: "2023 was another year of strong performance and growth for Diaceutics despite it being a challenging year for the wider pharma industry. This growth demonstrates the significant value our customers place on our differentiated offering, as reflected by the increasing number of precision medicines we are working with. The good momentum we enjoyed in 2023 has continued into 2024 to date and we see many opportunities for growth both with existing and potential new customers." Reports continued strong growth in the first quarter of 2024 with total contract value up 82% and revenue up 25% from a year prior. First quarter adjusted earnings before interest, tax, depreciation and amortisation and cash "in line with expectations" and accelerated investment strategy to scale for growth continuing to plan.

----------

Corre Energy BV - Groningen, Netherlands-based renewable energy storage and green hydrogen company - Reports results for the year to December 31. Swings to pretax profit of EUR2.3 million from EUR34.3 million loss a year prior. Reflects finance income of GBP13.8 million compared to finance expenses of GBP19.6 million a year ago. Explains the process to secure strategic investment into the business is ongoing following external interest which is being managed by Rothschild & Co. "There is no certainty that any investments will be made in this respect nor on the size and structure of such an investment," company says. Further, says: "The company intends to engage with its shareholders further over the coming weeks in relation to potential further funding of short-term working capital requirements ahead of this strategic investment process and long-term fund raise being concluded, based on reasonable expectation by the Directors that sufficient short-term funding can be raised from shareholders."

----------

TheWorks.co.uk PLC - Birmingham, England-based retailer - Issues trading update for the 53 weeks ended May 5. Reports revenue growth of 0.9% to GBP282.6 million in financial 2024 from GBP280.1 million a year prior and total like-for-like sales decline of 0.9%. Expects to report pre IFRS 16 adjusted earnings before interest, tax, depreciation and amortisation of around GBP6 million and deliver GBP8.5 million in financial 2025, in line with market forecasts. Medium term ambition is to return to pre IFRS 16 Ebitda margins of 5%, company says. "We are confident that the action taken to reduce costs and improve margins will offset the significant cost headwinds we face, including national living wage, higher freight costs and business rates," company says.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
29 Feb 2024 17:00

EARNINGS: Leeds awaiting Hemmers sale, Macfarlane ups full-year payout

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
29 Feb 2024 13:04

Oncimmune revenue falls as it implements new strategy

(Sharecast News) - Oncimmune reported revenue of £2.1m in its final results on Thursday, down from £3.8m for the prior extended 15-month period, with revenue from continuing operations totalling £1.2m.

Read more
19 Feb 2024 12:54

UK shareholder meetings calendar - next 7 days

Tuesday 20 February 
abrdn Equity Income Trust PLCAGM
Carr's Group PLCAGM
Dewhurst Group PLCAGM
Duke Royalty LtdEGM re changing name to Duke Capital
Wednesday 21 February 
Foresight Sustainable Forestry Co PLCAGM
Gooch & Housego PLCAGM
Tharisa PLCAGM
Thursday 22 February 
Bankers Investment Trust PLCAGM
Narf Industries PLCAGM
RWS Holdings PLCAGM
Sunrise Resources PLCAGM
Friday 23 February 
Blencowe Resources PLCAGM
Bluebird Merchant Ventures LtdAGM
Caledonian Trust PLCAGM
Chemring Group PLCAGM
Marble Point Loan Financing LtdEGM
Monday 26 February 
Oncimmune Holdings PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
30 Nov 2023 14:25

TRADING UPDATES: SkinBio launches food supplement on Amazon

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
12 Oct 2023 14:21

IN BRIEF: Oncimmune shares jump following new strategy update

Oncimmune Holdings PLC - Nottingham, England-based immunodiagnostics developer - Announces plans to focus on higher value customers, penetrating key accounts, partnering with key technology suppliers and launching new tools. Intends to accelerate new commercial contracts through partnerships with more contract research organisations to expand customer base, leverage auto-antibody analysis capabilities across new areas like companion diagnostics, and augment its commercial team. Also plans to expand its business models "beyond price-per-sample to more strategic partnership models" with upfront project and milestone success fees to better reflect its value. Update follows the disposal of Oncimmune Ltd in May, and the hiring of Martin Gouldstone as chief executive officer and Martin Hudson as finance director in August and September respectively. Company says final results for year ended August 31 will be released in due course.

Read more
12 Jul 2023 11:14

Oncimmune names chief executive successor, while finance chief leaves

(Alliance News) - Oncimmune Holdings PLC on Wednesday said it appointed Martin Gouldstone as its new chief executive, replacing Adam Hill who stepped down following the divestment of Oncimmune Ltd.

Read more
23 Jun 2023 12:08

Oncimmune Holdings shakes up leadership and unveils new growth plan

(Alliance News) - Oncimmune Holdings PLC on Friday said its chief executive officer will step down, as it unveiled a new plan for delivering refocused growth.

Read more
31 May 2023 13:31

Oncimmune shares plummet as interim revenue falls by fifth

(Alliance News) - Oncimmune Holdings PLC on Wednesday said revenue was down in the first half of its financial year due to delivery delays, but its loss narrowed.

Read more
22 May 2023 14:22

Oncimmune sells two subsidiaries to Freenome for GBP13 million

(Alliance News) - Oncimmune Holdings PLC on Monday said it has sold its subsidiaries Oncimmune Ltd and Oncimmune Europe GmbH to Freenome Holdings Inc, for GBP13 million in cash.

Read more
22 May 2023 11:14

Oncimmune sells 'non-core' lung and antibody assets in £13m deal

(Sharecast News) - Immunodiagnostics specialist Oncimmune announced the sale of its wholly-owned subsidiaries Oncimmune Limited and Oncimmune Europe to the US-based, privately-held Freenome Holdings on Monday.

Read more
22 May 2023 10:12

AIM WINNERS & LOSERS: Lansdowne and Barryroe slump after licence blow

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
20 Mar 2023 15:54

UK shareholder meetings calendar - next 7 days

Tuesday 21 March 
BlackRock Sustainable American Income Trust PLCAGM
Gresham House Renewable Energy VCT 2 PLCAGM
React Group PLCAGM
Starvest PLCAGM
Sureserve Group PLCAGM
Wynnstay Group PLCAGM
Zamaz PLCGM re terms and conditions modification
Wednesday 22 March 
abrdn Private Equity Opportunities Trust PLCAGM
Asia Strategic Holdings LtdAGM
Circle Property PLCEGM re final disposal and cancellation
Genel Energy PLCAGM
Harmony Energy Income Trust PLCAGM
Titon Holdings PLCAGM
Thursday 23 March 
Blackrock Throgmorton Trust PLCAGM
Crest Nicholson Holdings PLCAGM
Driver Group PLCAGM
Goldplat PLCAGM
Hardide PLCAGM
Idox PLCAGM
LPA Group PLCAGM
Zaim Credit Systems PLCGM re director removal and name change to Adalan Ventures PLC
Friday 24 March 
Faron Pharmaceuticals LtdAGM
In The Style Group PLCGM re sale of only subsidiary; becoming cash shell named Itsum PLC
Kitwave Group PLCAGM
Midatech Pharma PLCGM re cancellation of the admission to trading on AIM and name change
Quartix Technologies PLCAGM
SME Credit Realisation Fund LtdEGM re cancellation of the company's listing
Monday 27 March 
Let's Explore Group PLCGM re off-market purchase of the company's ordinary shares 
Oncimmune Holdings PLCGM re directors' remuneration
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
27 Feb 2023 14:27

EARNINGS SUMMARY: Base Resources profit surges; Spectral MD optimistic

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
27 Feb 2023 10:37

AIM WINNERS & LOSERS: Elixirr meets guidance, in strong start to 2023

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.